NEW YORK, Dec. 1 /PRNewswire/ -- Bristol-Myers Squibb Company today announced that it will voluntarily withdraw its securities from listing on NYSE Arca, Inc., formerly the Pacific Exchange. Bristol-Myers Squibb securities will continue to be listed on the New York Stock Exchange.
The decision to voluntarily withdraw listing from NYSE Arca, Inc. was made to eliminate duplicative administrative requirements inherent with dual listings as a result of the NYSE Group's recent merger with Achipelago Holdings, the parent company of NYSE Arca. NYSE Arca will continue trading Bristol-Myers Squibb securities on an unlisted trading privilege basis.
Bristol-Myers Squibb Company is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.
Bristol-Myers SquibbCONTACT: Media, Jeff Macdonald, Communications, +1-212-546-4824,jeffrey.macdonald@bms.com; or Investors, John Elicker, Investor Relations,+1-212-546-3775, john.elicker@bms.com
Web site: http://www.bms.com/
